Fortis Healthcare Ltd (FORTIS) — shareholding pattern, promoter holding, financials and share price

About Fortis Healthcare Ltd (FORTIS)

Fortis Healthcare Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as FORTIS and on the BSE under scrip code 532843. Its ISIN is INE061F01013.

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1] Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers. [2]

Fortis Healthcare is a leading integrated healthcare delivery provider in India operating 36 facilities across 12 states with over 6,000 operational beds (including O&M) and a large diagnostics franchise, offering multi‑specialty and quaternary services across Cardiac, Oncology, Neuro, Renal and other specialties under an integrated hospital and diagnostics model.

Q3 FY26 results show healthy top‑line and margin expansion: consolidated revenue grew 17.5% YoY to INR 2,265 Cr while operating EBITDA rose 34.8% to INR 505 Cr with a 22.3% margin; hospital revenues grew 19.4% and hospital EBITDA margin expanded to 21.7%, signaling improving operating leverage at Fortis Healthcare.

Listed peers in Hospital: Apollo Hospitals Enterprise Ltd, Max Healthcare Institute Ltd, Aster DM Healthcare Ltd, Narayana Hrudayalaya Ltd, Global Health Ltd, Krishna Institute of Medical Sciences Ltd.

Valuation & Returns

10 Jul 2026

At ₹968.65 a share on 10 Jul 2026, Fortis Healthcare Ltd (FORTIS) was valued at a price-to-earnings ratio of 68.72x against an industry P/E of 61.73x and a price-to-book of 8.2x on a book value of ₹118.11 per share as of Mar 2025. Solomo computes return on equity of 11.94% and return on capital employed of 14.75% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
68.72x
Industry P/E
61.73x
P/B
8.2x
EPS (TTM)
₹14.1
Book value / share
₹118.11
ROE
11.94%
ROCE
14.75%
ROA
7.77%
Debt / equity
0.28x
Dividend yield
0.1%
EBITDA margin
23.33%
52-week range
₹757.15 – ₹1,104.3

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Fortis Healthcare Ltd (FORTIS) reported revenue of ₹9,128 crore, net profit of ₹1,064 crore and earnings per share of ₹13.8. That compares with revenue of ₹7,783 crore and net profit of ₹809 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹2,365 crore and net profit ₹271 crore (consolidated).

Consolidated annual results for Fortis Healthcare Ltd (FORTIS), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)5,7186,2986,8937,7839,128
Net profit (₹ cr)7906336458091,064
EPS (₹)7.357.87.9310.2613.8
Compound annual growth for Fortis Healthcare Ltd (FORTIS). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth10.03%15.55%18.79%13.03%
Profit growth--34.10%-25.44%
Stock price CAGR19%33%43%21%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 31.17% of Fortis Healthcare Ltd (FORTIS) (unchanged from the previous quarter), foreign institutional investors (FII) hold 25.2% and domestic institutional investors (DII) hold 32.23%. Market capitalisation was ₹73,129 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2010.

Largest disclosed public shareholders in Jun 2026: HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUND 6.54%, KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE 5.76%, REKHA JHUNJHUNWALA 4.02%, AXIS MUTUAL FUND TRUSTEE LTD. A/C AXIS MUTUAL FUND 2.94%, NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA NIF 2.5%, SBI LIFE INSURANCE CO. LTD 1.73%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202631.17%-25.2%32.23%68.83%
Mar 202631.17%-25.97%31.35%68.83%
Dec 202531.17%-27.84%29.33%68.83%
Sep 202531.17%-27.9%29.14%68.83%
Jun 202531.17%-27.17%29.79%68.83%
Mar 202531.17%-27.4%29.46%68.83%
Dec 202431.17%-26.77%30.05%68.83%
Sep 202431.17%-25.26%30.73%68.83%
Every quarter since Sep 2010 Filing data, not investment advice.